Published Technical Disclosure Archive

Intelligent Opioid Overdose Prevention and Treatment System

Publication ID: 24-11857758_0008_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Opioid Overdose Prevention and Treatment System,” Published Technical Disclosure No. 24-11857758_0008_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857758_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,758.

Summary of the Inventive Concept

An innovative system integrating implantable drug delivery devices with AI, IoT, and blockchain technologies to prevent and treat opioid overdoses in real-time, ensuring timely intervention and secure data management.

Background and Problem Solved

The original patent addresses the need for implantable drug delivery devices for treating opioid overdoses. However, these devices have limitations in terms of real-time detection, secure data storage, and personalized treatment. The new inventive concept solves these problems by combining the implantable drug delivery device with advanced technologies to create a comprehensive and proactive system.

Detailed Description of the Inventive Concept

The system comprises an implantable drug delivery device, an IoT-enabled sensor for detecting physiological reactions to an overdose, and a blockchain-based authentication mechanism for secure data storage and transmission. The device is integrated with an AI-powered overdose prediction algorithm that analyzes a patient's medical history and sensor data to predict the likelihood of an overdose and trigger the device to release a counteracting drug. The system also includes a wearable device with a machine learning-based sensor for detecting abnormal vital signs and a communication module for alerting emergency services in the event of an overdose.

Novelty and Inventive Step

The new claims introduce a synergistic combination of AI, IoT, and blockchain technologies with implantable drug delivery devices, enabling real-time overdose detection, secure data management, and personalized treatment. This integration is novel and non-obvious compared to the original patent, which only addresses the implantable device itself.

Alternative Embodiments and Variations

Alternative embodiments of the system could include using different types of sensors, such as ECG or blood oxygen level sensors, or integrating the system with existing wearable devices or mobile apps. Variations could also include using different AI algorithms or machine learning models to improve the accuracy of overdose prediction.

Potential Commercial Applications and Market

The Intelligent Opioid Overdose Prevention and Treatment System has significant commercial potential in the healthcare industry, particularly in the areas of emergency medicine, addiction treatment, and pharmaceuticals. The system could be marketed to hospitals, clinics, and emergency services, as well as to individuals and families affected by opioid addiction.

CPC Classifications

SectionClassGroup
A A61 A61M5/14276
A A61 A61B5/4839
A A61 A61B5/4845
A A61 A61B5/4848
A A61 A61K9/0024
A A61 A61K9/0097
A A61 A61M5/44
A A61 A61M31/002
A A61 A61M37/0069
A A61 A61B5/01
A A61 A61F2250/0068
A A61 A61K31/485

Field of Art

Medical Device Technology, specifically drug delivery systems, biosensors, and implantable medical devices with a focus on overdose prevention and treatment technologies

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in implantable drug delivery systems, sensor technologies, machine learning applications in healthcare, and knowledge of IoT and blockchain integration in medical technologies

Obviousness Rationale

A PHOSITA would recognize that integrating AI, IoT, and blockchain technologies with the existing implantable drug delivery device represents a predictable combination of known technologies to enhance the functionality and monitoring capabilities of the original device. The core drug delivery mechanism remains fundamentally consistent with the source patent, while the additional technologies provide incremental improvements in detection, tracking, and intervention. These technological extensions represent logical and foreseeable advancements in medical device design that would be obvious to a skilled practitioner seeking to improve patient safety and device performance.

Obvious Combinations & Variations

Source Patent Element
Implantable drug delivery device with a reservoir for containing naloxone or similar overdose-treating drugs
PTD Variation
Adding IoT-enabled sensors for real-time physiological monitoring and AI-powered overdose prediction algorithms
Obviousness Reasoning
Integrating sensor technologies with medical devices is a known technique, and using machine learning to predict medical events is a predictable application of existing AI technologies in healthcare monitoring
Source Patent Element
Temporary seal formed of biocompatible cross-linked polymer
PTD Variation
Blockchain-based authentication and tracking mechanism for device deployment and maintenance
Obviousness Reasoning
Implementing secure tracking systems for medical devices is a logical extension of existing device management practices, representing a design choice to improve device accountability and regulatory compliance
Source Patent Element
Method of delivering drug in response to physiological reaction to opioid overdose
PTD Variation
Adding a wearable communication module to alert emergency services and provide additional vital sign monitoring
Obviousness Reasoning
Expanding medical device functionality to include emergency communication is a predictable solution for improving patient safety, utilizing known communication technologies in a medical context
Source Patent Element
Single-use implantable drug delivery device for overdose treatment
PTD Variation
Machine learning algorithms for optimizing device performance through continuous sensor data collection and analysis
Obviousness Reasoning
Using data analytics to improve medical device performance is a standard approach in medical technology, representing an obvious method of iterative device improvement
Source Patent Element
Drug delivery method targeting specific physiological reactions
PTD Variation
Expanding sensor types to include ECG and blood oxygen level monitoring for more comprehensive overdose detection
Obviousness Reasoning
Selecting alternative sensor technologies for physiological monitoring is a routine design choice with predictable results in medical device development
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in this publication would be obvious to a person having ordinary skill in the art at the time of invention, when considered in light of US Patent 11857758. The incremental technological extensions represent predictable combinations of known techniques in medical device design, sensor technologies, and digital health monitoring, thereby rendering potential claims covering similar innovations unpatentable as obvious variations of the prior art.

Original Patent Information

Patent NumberUS 11,857,758
TitleDrug delivery device and method
Assignee(s)Purdue Research Foundation